Kunwei Shen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Early Breast Cancer

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Genome Wide Identification

Top Venues

Journal of breast cancer

OncoTargets and therapy

Proceedings of the National Academy of Sciences of the United States of America

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Siji Zhu, Yujie Lu, Xiaochun Fei, Kunwei Shen, Xiaosong Chen
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases. British journal of cancer (2023)
Cixiang Zhou, Difei Wang, Jingchi Li, Qiuyu Wang, Lulu Wo, Xin Zhang, Zhexuan Hu, Zheng Wang, Mengna Zhan, Ming He, Guohong Hu, Xiaosong Chen, Kunwei Shen, Guo-Qiang Chen, Qian Zhao
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2 . Proceedings of the National Academy of Sciences of the United States of America 119 (39) (2022)
Jing Yu, Jiayi Wu, Ou Huang, Xiaosong Chen, Kunwei Shen
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study. Journal of medical Internet research 23 (9) (2021)
Jin Hong, Weiwei Rui, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer. Cancer medicine 10 (22) (2021)
Yujie Lu, Yiwei Tong, Jiahui Huang, Lin Lin, Jiayi Wu, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis. Cancer management and research 13 (2021)
Xi Sun, Shuning Ding, Shuangshuang Lu, Zheng Wang, Xiaosong Chen, Kunwei Shen
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer. OncoTargets and therapy 14 (2021)
Yifei Zhu, Tiange Wang, Jiayi Wu, Ou Huang, Li Zhu, Jianrong He, Yafen Li, Weiguo Chen, Xiaosong Chen, Kunwei Shen
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women. OncoTargets and therapy 13 (2020)
Yuhao Gao, Xiaosong Chen, Qing He, Ryan C Gimple, Yajin Liao, Liang Wang, Rong Wu, Qi Xie, Jeremy N Rich, Kunwei Shen, Zengqiang Yuan
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin. Proceedings of the National Academy of Sciences of the United States of America 117 (52) (2020)
Yufei Zeng, Weiqi Gao, Xiaosong Chen, Kunwei Shen
Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component. British journal of cancer 124 (5) (2020)
Jin Hong, Jiahui Huang, Lili Shen, Siji Zhu, Weiqi Gao, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis. BMC cancer 20 (1) (2020)
Qiong Fang, Jiahui Huang, Lu Gan, Kunwei Shen, Xiaosong Chen, Beiwen Wu
Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer. Journal of breast cancer 22 (3) (2019)